Evaluating Methotrexate: Challenges in JIA Treatment Evidence

This chapter critiques the limitations of clinical trials on methotrexate for juvenile idiopathic arthritis, noting issues with dosing and duration. The Medicine by the Numbers team emphasizes the need for more comprehensive research to establish effective treatment protocols.